Please provide your email address to receive an email when new articles are posted on . Individuals with pre-bronchodilator airflow obstruction appeared to be at significant risk for future COPD ...

Although there is significant improvement in managing asthma and chronic obstructive pulmonary disease (COPD) diseases, there is still a strong need in controlling symptoms to prevent hospitalizations ...

The IMPACT and ETHOS trials showed that single-inhaler triple therapy significantly reduce the rate of COPD exacerbation and mortality compared with dual bronchodilators. Findings are from an ...

Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make it easier to breathe -- do little to help people who do not have chronic obstructive pulmonary ...

Current or former smokers who ha­ve clinically significant respiratory symptoms but no spirometric evidence of airway obstruction are often treated with dual bronchodilators commonly prescribed for ...

"In patients with risk factors for COPD and respiratory symptoms, referring for spirometry is important to triage who will and won’t benefit from bronchodilators." – Meilan Han, MD, Professor of ...

Inhaled dual bronchodilator therapy did not decrease respiratory symptoms in former or current smokers with preserved lung function, the RETHINC trial showed. Among 535 symptomatic smokers with a 10 ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people ...

Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...

COPD stands for chronic obstructive pulmonary disease. The condition causes lung inflammation that leads to airflow blockage and breathing problems. [1] “COPD encompasses both emphysema and chronic ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators – long-lasting inhalers that relax the airways and make it easier to breathe – do little to help people ...